We analyzed if the expression of MYD88 in blood and bone marrow samples in CLL patients depends on the prognostic markers including the mutational status of IGHV genes, ZAP-70 expression, CD38 expression, and Binet stage. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.